News

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...
Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...
There’s more than one way to build a portfolio of dividend stocks. The classic move is to buy some individual large-cap ...
Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...
Pharmaceutical company Eli Lilly has announced plans to acquire private biotech company SiteOne in a deal worth up to $1 ...
Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...
Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a ...
Purdue’s Mung Chiang outlines a bold vision to transform university research funding through deeper industry, philanthropic, ...
Eli Lilly’s acquisition of SiteOne Therapeutics comes ahead of Phase 2 testing of the startup’s lead drug candidate, which ...
Swiss President Karin Keller-Sutter will visit pharma powerhouse Ireland tomorrow for high-level talks ahead of President ...
The supply of GLP-1 drugs has been increasing, but they’re still expensive for most patients. Here are answers to some ...
Global biopharma Eli Lilly will acquire SiteOne Therapeutics, a biotech dedicated to the development of non-opioid medicines ...